Title : Preclinical and phase 1 clinical characterization of CI-979\/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease - Sedman_1995_Life.Sci_56(11-12)_877 |
Author(s) : Sedman AJ , Bockbrader H , Schwarz RD |
Ref : Life Sciences , 56(11-12) :877 , 1995 |
Abstract : Sedman_1995_Life.Sci_56(11-12)_877 |
ESTHER : Sedman_1995_Life.Sci_56(11-12)_877 |
PubMedSearch : Sedman_1995_Life.Sci_56(11-12)_877 |
PubMedID: 10188788 |
Sedman AJ, Bockbrader H, Schwarz RD (1995)
Preclinical and phase 1 clinical characterization of CI-979\/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease
Life Sciences
56(11-12) :877
Sedman AJ, Bockbrader H, Schwarz RD (1995)
Life Sciences
56(11-12) :877